College of Medicine – Phoenix
When
Mark W. Feinberg, MD, is a cardiologist and vascular biologist at Brigham and Women’s Hospital and a professor of medicine at Harvard Medical School. Dr. Feinberg is program director of Cardiovascular RNA Biology Research at BWH and investigates signaling events that control vascular inflammation and angiogenesis as it relates to a range of ischemic cardiovascular disease states, including atherosclerosis and its complications involving ischemic injury in the heart (myocardial infarction) and limb (peripheral artery disease), with a special focus on diabetes.
His group has discovered noncoding RNAs (microRNAs and lncRNAs) and their interactors, with the aim of translating these findings into novel therapeutic approaches for ischemic cardiovascular and cardiometabolic disease. Dr. Feinberg has held various leadership roles in cardiovascular research, including his service on international and national peer review grant study sections, editorial service and as a co-chair of the Brigham Research Institute’s CVDM (cardiovascular, diabetes and metabolic disorders) Center. He served as cirector of an AHA SFRN center on cardiometabolic disease and is associate program director of the BWH Cardiology Fellowship training program.
Dr. Feinberg is an elected member of the American Society of Clinical Investigation, the Association of University Cardiologists and the American Association for the Advancement of Science.